Discover
CRBP
Corbus Pharmaceuticals Holdings, Inc.
8.98
1 x 8.05
1 x 9.99
bid
ask
+
0.09
1.01%
1 @ 04:00 PM
9.28 +0.30 (3.35%)
| Ytd | 10.32% | |
| 1y | 4.91% |
8.83
day range
9.05
7.12
52 week range
20.56
| Open | 8.93 | Prev Close | 8.89 | Low | 8.83 | High | 9.05 | Mkt Cap | 112.57M |
| Vol | 80.45K | Avg Vol | 495.85K | EPS | -5.82 | P/E | -1.54 | Forward P/E | -2.51 |
| Beta | 2.55 | Short Ratio | 8.28 | Inst. Own | 105.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 9.00 | 200-d Avg | 10.03 | 1yr Est | 56.78 |
| Income Statement | |||
| Operating Expenses | 24.30M | ||
| Research and Development Expense | 19.82M | ||
| Selling, General and Administrative Expense | 4.49M | ||
| Operating Income | -24.30M | ||
| Net Income | -22.97M | ||
| Net Income Common Stock | -22.97M | ||
| Net Income Common Stock (USD) | -22.97M | ||
| Consolidated Income | -22.97M | ||
| Earnings per Basic Share | -1.23 | ||
| Earnings per Basic Share (USD) | -1.23 | ||
| Earnings per Diluted Share | -1.23 | ||
| Earning Before Interest & Taxes (EBIT) | -22.97M | ||
| Earning Before Interest & Taxes (USD) | -22.97M | ||
| Weighted Average Shares | 18.71M | ||
| Weighted Average Shares Diluted | 18.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.05M | ||
| Cash and Equivalents (USD) | 26.05M | ||
| Investments | 112.56M | ||
| Investments Current | 112.56M | ||
| Current Assets | 143.57M | ||
| Property, Plant & Equipment Net | 914.00K | ||
| Total Assets | 144.48M | ||
| Debt Current | 1.21M | ||
| Total Debt | 1.21M | ||
| Current Liabilities | 18.14M | ||
| Total Liabilities | 18.14M | ||
| Accumulated Retained Earnings (Deficit) | -578.40M | ||
| Accumulated Other Comprehensive Income | -161.00K | ||
| Shareholders Equity | 126.34M | ||
| Shareholders Equity (USD) | 126.34M | ||
| Assets Non-Current | 914.00K | ||
| Total Debt (USD) | 1.21M | ||
| Trade and Non-Trade Payables | 435.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 49.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.12M | ||
| Capital Expenditure | -6.00K | ||
| Net Cash Flow from Investing | 22.46M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 22.46M | ||
| Net Cash Flow from Operations | -25.57M | ||
| Share Based Compensation | 1.92M | ||